Multicenter prospective study of the efficacy and safety of combined immunosuppressive therapy with high-dose glucocorticoid, tacrolimus, and cyclophosphamide in interstitial lung diseases accompanied by anti-melanoma differentiation-associated gene 5-positive dermatomyositis - Tsuji, H; Nakashima, R; Hosono, Y (Arthritis Rheumatol, 2020)
et al.